Variations in expression patterns (mainly in ABCB1/multidrug resistance protein (MDR1), ABCG2/BCRP and ABCCs/MRPs) have been linked to toxicity and resistance to therapeutic agents, particularly in cancer chemotherapy [7, 8]. The gene discussed is ABCG2; the disease is cancer.